Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Beam Therapeutics (BEAM) Asset Utilization Ratio (2020 - 2025)

Beam Therapeutics (BEAM) has disclosed Asset Utilization Ratio for 6 consecutive years, with 0.1 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 79.27% to 0.1 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.1, a 79.27% increase, with the full-year FY2025 number at 0.11, up 118.18% from a year prior.
  • Asset Utilization Ratio was 0.1 for Q4 2025 at Beam Therapeutics, up from 0.04 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.29 in Q3 2024 to a low of 0.0 in Q2 2021.
  • A 5-year average of 0.09 and a median of 0.05 in 2022 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: skyrocketed 176929.34% in 2022, then crashed 85.66% in 2025.
  • Beam Therapeutics' Asset Utilization Ratio stood at 0.04 in 2021, then rose by 14.85% to 0.05 in 2022, then skyrocketed by 506.87% to 0.27 in 2023, then crashed by 79.67% to 0.06 in 2024, then skyrocketed by 79.27% to 0.1 in 2025.
  • Per Business Quant, the three most recent readings for BEAM's Asset Utilization Ratio are 0.1 (Q4 2025), 0.04 (Q3 2025), and 0.04 (Q2 2025).